Ayala Pharmaceuticals Inc (ADXS)
0.437
-0.12
(-21.96%)
USD |
OTCM |
May 10, 15:29
Ayala Pharmaceuticals Total Return Level: 0.56 for May 9, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 09, 2024 | 0.56 |
May 08, 2024 | 0.625 |
May 07, 2024 | 0.5305 |
May 06, 2024 | 0.55 |
May 03, 2024 | 0.555 |
May 02, 2024 | 0.5305 |
May 01, 2024 | 0.6431 |
April 30, 2024 | 0.665 |
April 29, 2024 | 0.665 |
April 26, 2024 | 0.555 |
April 25, 2024 | 0.55 |
April 24, 2024 | 0.54 |
April 23, 2024 | 0.54 |
April 22, 2024 | 0.572 |
April 19, 2024 | 0.572 |
April 18, 2024 | 0.57 |
April 17, 2024 | 0.6455 |
April 16, 2024 | 0.601 |
April 15, 2024 | 0.621 |
April 12, 2024 | 0.668 |
April 11, 2024 | 0.6679 |
April 10, 2024 | 0.61 |
April 09, 2024 | 0.61 |
April 08, 2024 | 0.668 |
April 05, 2024 | 0.607 |
Date | Value |
---|---|
April 04, 2024 | 0.607 |
April 03, 2024 | 0.627 |
April 02, 2024 | 0.64 |
April 01, 2024 | 0.64 |
March 28, 2024 | 0.64 |
March 27, 2024 | 0.70 |
March 26, 2024 | 0.71 |
March 25, 2024 | 0.63 |
March 22, 2024 | 0.60 |
March 21, 2024 | 0.59 |
March 20, 2024 | 0.60 |
March 19, 2024 | 0.6222 |
March 18, 2024 | 0.5974 |
March 15, 2024 | 0.62 |
March 14, 2024 | 0.67 |
March 13, 2024 | 0.70 |
March 12, 2024 | 0.74 |
March 11, 2024 | 0.72 |
March 08, 2024 | 0.7721 |
March 07, 2024 | 0.79 |
March 06, 2024 | 0.75 |
March 05, 2024 | 0.7647 |
March 04, 2024 | 0.8405 |
March 01, 2024 | 0.911 |
February 29, 2024 | 0.861 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.40
Minimum
Jan 04 2023
270.40
Maximum
May 10 2019
30.27
Average
24.80
Median
Oct 24 2019
Total Return Level Benchmarks
NovaBay Pharmaceuticals Inc | 0.0893 |
Palatin Technologies Inc | 2.35 |
iBio Inc | 1.88 |
Theriva Biologics Inc | 0.404 |
Oragenics Inc | 1.38 |